Ikena Oncology Inc reports results for the quarter ended in September - Earnings Summary

ImageneBio

08/11/2022 14:31

* Ikena Oncology Inc  IKNA.OQ  reported a quarterly adjusted
loss
of 48 cents​​ per share for the quarter ended in September. The
mean expectation of five analysts for the quarter was for a loss
of 50 cents per share.
    * Revenue rose 70.9% to $6.40 million from a year ago;
analysts
expected $4.32 million. 
    * Ikena Oncology Inc's reported EPS for the quarter was a
loss
of 48 cents​.
    * The mean earnings estimate of analysts had risen by
about 4.5%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Ikena Oncology Inc shares had fallen by 35.2% this
quarter and
lost 81.7% so far this year.
    * The company reported a quarterly loss of $17.39 million.
    * Wall Street's median 12-month price target for Ikena
Oncology
Inc is $26.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
8 at 02:31 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.50          -0.48          Beat
 Jun. 30 2022      -0.49          -0.57          Missed
 Mar. 31 2022      -0.42          -0.47          Missed
 Dec. 31 2021      -0.51          0.07           Beat